Dr. Michael Kenneth Mesisca, DO

Dr. Mesisca practices at Riverside University Medical Center in Moreno Valley, California.

Dr. Mesisca's NPI, 1831426840, was assigned on November 11, 2009. Dr. Mesisca graduated from WesternU College of Osteopathic Medicine of the Pacific in 2008. Dr. Mesisca holds California license 20A10981.

Dr. Mesisca's primary practice is Riverside University Medical Center, at 26520 Cactus Ave, Moreno Valley, CA 92555 in Riverside County. The practice phone is (951) 486-4458.

Dr. Mesisca's primary practice is Riverside University Medical Center in Moreno Valley, California. Dr. Mesisca is also affiliated with Riverside University Health System - Medical Center. The medical group on file is Vituity. Dmand AI also links Dr. Mesisca to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mesisca practices, 2 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Mesisca's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Mesisca is board certified in emergency medicine by the AOA Board of Emergency Medicine. Dr. Mesisca is licensed in California.

CMS data shows 100 Medicare services from Dr. Mesisca across 3 procedure codes in 2024, for 98 Medicare patients. Medicare paid $14,293 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 98 Medicare patients who saw Dr. Mesisca in 2024. The largest group is 65 to 74, with 35 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 69% are also on Medicaid. Their average risk score is 2.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mesisca's median patient age at 42, with 59% women.

In 2024, Dr. Mesisca wrote 90 Medicare Part D claims for 74 patients. 92% of them were for generic drugs. CMS names the drug for 26 of them, across 2 drugs with 11 or more claims each, at $125 in total drug cost. In 2018, CMS named 14 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Mesisca for performance year 2024, reported as part of a group. Dr. Mesisca accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Dr. Mesisca, published from 2020 to 2025. 2022 was the busiest year, with 3. The most frequent topics are COVID-19, SARS-CoV-2 and Pandemics. Dr. Mesisca's most frequent co-authors are Melanie Randall, MD, Thomas F. Minahan, DO and Timothy Paul Nesper, MD.

CMS Open Payments shows 3 general payments to Dr. Mesisca from 3 drug and device companies from 2020 to 2023. Food and beverage make up the largest share, 100% of the total. Davol Inc. paid the most, $22.

Dr. Mesisca graduated from WesternU College of Osteopathic Medicine of the Pacific in 2008. Dr. Mesisca is a member of AOA.

Dr. Mesisca is in network with 7 carriers, including United Healthcare, Molina and Aspirus Health Plan. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.